Ads
related to: combination drugs for hiv patients pictures in order of action- Helpful Resources
Learn About An HIV Treatment
And Discover More About Dosing.
- Treatment Costs & Savings
See If You Are Eligible For Savings
Or Assistance Programs.
- Helpful Patient Tools
Find Information For Patients Here.
Visit The Official Patient Website.
- HIV Treatment Injectable
Learn About A Treatment Option
And Find More Info Online Today.
- Long-Acting HIV Treatment
Injections Just Every Other Month
With A Flexible Treatment Window.
- Get Treatment Resources
See Tools Specifically For Patients
About Dosing, Savings And More.
- Helpful Resources
Search results
Results From The WOW.Com Content Network
Antiretroviral drugs are used to manage HIV/AIDS. Multiple antiretroviral drugs are often combined into a single pill in order to reduce pill burden. Some of these combinations are complete single-tablet regimens; the others must be combined with additional pills to make a treatment regimen.
Schematic description of the mechanism of the four classes of available antiretroviral drugs against HIV. There are six classes of drugs, which are usually used in combination, to treat HIV infection. Antiretroviral (ARV) drugs are broadly classified by the phase of the retrovirus life-cycle that the drug inhibits. Typical combinations include ...
Lamivudine/zidovudine, sold under the brand name Combivir among others, is a fixed-dose combination antiretroviral medication used to treat HIV/AIDS. [2] It contains two antiretroviral medications, lamivudine and zidovudine. [2] It is used together with other antiretrovirals. [2] It is taken by mouth twice a day. [2] [3]
Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) of HIV-1. Tenofovir is a nucleotide reverse transcriptase inhibitor of HIV-1, and it can be classified as an NtRTI. These three drugs work in combination to target the HIV reverse transcriptase protein in three ways, which reduces the virus's capacity to mutate. [5]
The drug was co-developed by Gilead Sciences and Johnson & Johnson's Tibotec division and was approved by the US Food and Drug Administration (FDA) in August 2011, and by the European Medicines Agency in November 2011, [3] [5] for patients who have not previously been treated for HIV. [6]
As with many medications targeting reverse transcriptase, body fat redistribution syndrome may occur, causing body fat to center on the upper back and neck, breast, and torso, and potentially decreasing around the legs, arms, and face. [11]
Ads
related to: combination drugs for hiv patients pictures in order of action